NCT06947993 Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis Status RECRUITING Phase PHASE2
NCT06941792 Inclisiran Effectiveness in China: a Pragmatic Randomized Trial Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06934967 Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients Status RECRUITING Phase PHASE3
NCT06931691 A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China Status RECRUITING Phase N/A
NCT06930859 Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia Status RECRUITING Phase N/A
NCT06923124 A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life Status COMPLETED Phase N/A
NCT06910813 DFT383 in Pediatric Participants With Nephropathic Cystinosis Status RECRUITING Phase PHASE1/PHASE2
NCT06909565 Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention Status RECRUITING Phase PHASE4
NCT06905327 A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects Status COMPLETED Phase PHASE1
NCT06905301 Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice Status RECRUITING Phase N/A
NCT06905288 Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. Status RECRUITING Phase N/A
NCT06903234 Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06899750 E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control Status RECRUITING Phase NA
NCT06897657 A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients Status COMPLETED Phase N/A
NCT06894511 An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06881823 Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC Status WITHDRAWN Phase PHASE1/PHASE2
NCT06869785 Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06868290 Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA Status RECRUITING Phase PHASE2
NCT06868212 A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines Status RECRUITING Phase PHASE3